Clinical activity of pembrolizumab (P) in undifferentiated pleomorphic sarcoma (UPS) and dedifferentiated/pleomorphic liposarcoma (LPS): Final results of SARC028 expansion cohorts Meeting Abstract
| Authors: | Burgess, M. A.; Bolejack, V.; Schuetze, S.; Van Tine, B. A.; Attia, S.; Riedel, R. F.; Hu, J. S.; Davis, L. E.; Okuno, S. H.; Priebat, D. A.; Movva, S.; Reed, D. R.; D'Angelo, S. P.; Lazar, A. J.; Keung, E. Z. Y.; Reinke, D. K.; Baker, L. H.; Maki, R. G.; Patel, S.; Tawbi, H. A. H. |
| Abstract Title: | Clinical activity of pembrolizumab (P) in undifferentiated pleomorphic sarcoma (UPS) and dedifferentiated/pleomorphic liposarcoma (LPS): Final results of SARC028 expansion cohorts |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 565s |
| Language: | English |
| ACCESSION: | WOS:000487345804112 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2019.37.15_suppl.11015 |
| Notes: | Meeting Abstract: 11015 -- Source: Wos |
